Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06299748
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-02-22
Brief Title:
A Worldwide Pregnancy Safety Study to Assess Maternal Fetal and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy andor Breastfeeding
Sponsor:
Organization:
argenx
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
1 Year
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
279
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Other |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 104452 |
Who Masked List: